Beth Brown
Medical · Santa Maria, CANPI 1184958837
Payments from drug & device makers
Across 475 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Collegium Pharmaceutical, Inc.$2K
- Pfizer$640
- Relievant Medsystems, Inc.$415
- IBSA Pharma Inc.$338
- plus $3K from 25 others
What the payments were for
- Food & beverage$9,205100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 92 | $1,877 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 84 | $1,545 |
| Collegium Pharmaceutical, Inc. | 84 | $1,503 |
| Pfizer | 34 | $640 |
| Relievant Medsystems, Inc. | 17 | $415 |
| IBSA Pharma Inc. | 18 | $338 |
| Amgen(2 entities) | 14 | $333 |
| Azurity Pharmaceuticals, Inc. | 16 | $332 |
| Vertex | 9 | $307 |
| Biohaven Pharmaceuticals, Inc. | 15 | $278 |
| Scilex Pharmaceuticals Inc. | 14 | $236 |
| Arbor Pharmaceuticals, Inc. | 14 | $192 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $180 |
| Teva Pharmaceuticals USA, Inc. | 7 | $143 |
| Lilly USA, LLC | 7 | $135 |
| Almatica Pharma LLC | 5 | $120 |
| GRT US Holding, Inc. | 3 | $86 |
| Redhill Biopharma Inc. | 3 | $65 |
| Biodelivery Sciences International, Inc. | 4 | $61 |
| Novartis | 4 | $57 |
| Hikma Pharmaceuticals USA | 3 | $53 |
| Virtus Pharmaceuticals LLC | 3 | $53 |
| Indivior Inc. | 2 | $52 |
| Medtronic | 2 | $51 |
| Upsher-smith Laboratories LLC | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
| Bioventus LLC | 1 | $23 |
| Boston Scientific | 1 | $22 |
| West Therapeutics Development, LLC | 1 | $16 |
| Tonix Medicines, Inc. | 1 | $16 |
| MML US, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,205 in reported general payments places this provider in the 90th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 40 | $92,315 |
| Nurtec OdtRimegepant Sulfate | 52 | $84,703 |
| OxycontinOxycodone Hcl | 101 | $61,448 |
| BelbucaBuprenorphine Hcl | 47 | $46,279 |
| UbrelvyUbrogepant | 26 | $40,757 |
| Aimovig AutoinjectorErenumab-Aooe | 39 | $39,445 |
| Xtampza ErOxycodone Myristate | 51 | $33,599 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,176 | $26,525 |
| Fentanyl | 125 | $21,014 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 127 | $20,708 |
| MovantikNaloxegol Oxalate | 47 | $20,445 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 698 | $18,478 |
| HorizantGabapentin Enacarbil | 14 | $16,645 |
| Buprenorphine | 52 | $14,248 |
| SymproicNaldemedine Tosylate | 30 | $13,767 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,545 | $92,31540 claims |
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta | $1,503 | $91,561126 claims |
| PfizerNurtec Odt, Lyrica | $640 | $91,52864 claims |
| AbbVieUbrelvy, Linzess | $1,877 | $49,35838 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Buprenorphine, Buprenorphine Hcl, Morphine Sulfate | $53 | $40,619397 claims |
| Redhill Biopharma Inc.Movantik | $65 | $20,44547 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $192 | $16,64514 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $236 | $12,43530 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 medical providers in California.
Other medical in Santa Maria
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.